Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

ResMed Inc. (RMD) had Revenue of $1.46B for the most recently reported fiscal quarter, ending 2026-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2026-06-30

Income Statement Financials
Revenue	$1.46B
Net Income	$383.43M
Cost of Goods Sold	$602.43M
Gross Profit	$861.22M
Operating Expenses	$1.01B
Operating Income	$448.71M
Non-Operating Income/Expense	$25.45M
Pre-Tax Income	$474.16M
Normalized Pre-Tax Income	$474.16M
Income after Taxes	$383.43M
Income from Continuous Operations	$383.43M
Consolidated Net Income/Loss	$383.43M
Normalized Income after Taxes	$383.43M
EBIT	$448.71M
EBITDA	$503.83M
Weighted-Average Shares Outstanding (Basic)	145.52M
Weighted-Average Shares Outstanding (Diluted)	146.05M
Earnings per Share (EPS) (Basic)	$2.66
Earnings per Share (EPS) (Diluted)	$2.64
Balance Sheet Financials
Current Assets	$4.32B
Property, Plant, and Equipment	$581.83M
Long-Term Assets	$4.64B
Total Assets	$8.97B
Current Liabilities	$1.40B
Long-Term Debt	$399.42M
Long-Term Liabilities	$985.45M
Total Liabilities	$2.38B
Common Equity	$6.59B
Tangible Shareholders Equity	$3.22B
Shareholders Equity	$6.59B
Common Shares Outstanding	144.24M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$1.81B
Cash Flow from Investing Activities	$-545.20M
Cash Flow from Financial Activities	$-1.01B
Beginning Cash	$1.21B
End Cash	$1.47B
Increase/Decrease in Cash	$259.78M
Stock-Based Compensation	$104.35M
Common Stock Dividends Paid	$-349.66M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.10
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.06
Debt to Equity Ratio	0.10
Gross Margin	58.84%
Operating Margin	30.66%
EBIT Margin	30.66%
EBITDA Margin	--
Pre-Tax Profit Margin	32.40%
Profit Margin	26.20%
Free Cash Flow	$1.65B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.16
Inventory Turnover	0.64
Receiveable Turnover	1.41
Days Sales in Receivables	63.72
Return on Equity	5.82%
Return on Tangible Equity	11.90%
Return on Assets	4.28%
Return on Investments	5.49%
Book Value Per Share	$45.66
Free Cash Flow per Share	$11.29
Operating Cash Flow per Share	$12.36

Data from Zacks Investment Research, Inc.